Mer­ck scoops up new chief mar­ket­ing of­fi­cer from Bio­gen's neu­rol­o­gy busi­ness

4 days ago
Pharma
Marketing

No­var­tis los­es patent ap­peal for block­buster MS drug, open­ing the door to gener­ic ri­vals

5 days ago
Pharma
Law

#Can­nes­Lions2022 Mar­ket­ingRx roundup: Li­ons health down­size gets mixed re­views; An­ti-obe­si­ty cam­paign wins Grand Prix

5 days ago
Pharma
Marketing

#Can­nes­Lions2022: P&G mar­ket­ing leg­end Marc Pritchard pitch­es cre­ativ­i­ty for growth — and good

5 days ago
Pharma
Marketing

#Can­nes­Lions2022: Wal­greens buys in­to clin­i­cal tri­als as cre­ative team takes a new post-Covid tone

5 days ago
Pharma
Marketing

Big da­ta meets Big Phar­ma: Pfiz­er buys re­al-time pa­tient re­sults in col­lab­o­ra­tion with Tru­ve­ta

5 days ago
R&D

PTC of­fers its best case for a con­tro­ver­sial Duchenne MD PhI­II. But key fail­ures spark fresh doubts of suc­cess at FDA

5 days ago
R&D

Medicare could save more than $3B an­nu­al­ly by us­ing Mark Cuban's new on­line gener­ic drug com­pa­ny — study

5 days ago
Pharma

#Can­nes­Lions2022: IPG Health nabs health­care net­work and ad agency hon­ors, while VM­LY&R cel­e­brates dou­ble Grand Prix wins

5 days ago
Pharma
Marketing

#Can­nes­Lions2022: 'Raise the bar': Bay­er con­sumer mar­ket­ing head looks to give phar­ma cre­ativ­i­ty a lit­tle push

5 days ago
Pharma
Marketing

Mer­ck touts new da­ta for break­through pneu­mo­coc­cal vac­cine as it heads to PhI­II tri­als

5 days ago
R&D
Pharma

As­traZeneca says its $200M cash bet on Io­n­is’ AT­TR drug is pay­ing off — with PhI­II da­ta set­ting up FDA fil­ing

5 days ago
R&D

#Can­nes­Lions2022: J&J and Bay­er nab health and well­ness wins in tech-filled cat­e­go­ry

6 days ago
Pharma
Marketing

#Can­nes­Lions2022: Phar­ma cre­ativ­i­ty awards shine spot­light on Hori­zon, Evofem and Ab­bott

6 days ago
Pharma
Marketing

Lat­est news on thumbs down for Nu­plazid; Amy­lyx’s first ALS ap­proval; Buy­out buzz for trou­bled biotechs; Cannes Li­ons pre­view; and more

Last week
Weekly

UP­DAT­ED: FDA ad­vi­sors most­ly agree that Aca­dia’s Nu­plazid is­n't ef­fec­tive at treat­ing Alzheimer’s-re­lat­ed psy­chosis

Last week
FDA+

Tee­ter­ing on the brink, Clo­vis aban­dons an ear­ly ap­proval for Rubra­ca

Last week
R&D

Gal­der­ma kicks off aes­thet­ics brand cam­paign at New York City Pride­Fest

Last week
Pharma
Marketing

J&J inks clin­i­cal tri­al deal with Stand Up To Can­cer, lat­est phar­ma to join can­cer non­prof­it study ef­forts

Last week
Pharma
Marketing

Up­dat­ed: Mer­ck look­ing at Seagen takeover bid in the wake of Clay Sie­gal­l's res­ig­na­tion — re­port

Last week
Deals
Pharma

In at­tempt­ed bear mar­ket brush­back, SMA play­er Schol­ar Rock nabs $205M raise on open-la­bel ex­ten­sion da­ta

Last week
Financing
R&D

SPAC deal touch­es down for mi­cro­cap biotech armed with a PhII, for­mer Pfiz­er mon­o­clon­al an­ti­body

Last week
Financing

Buy­out buzz: Is As­traZeneca hunt­ing a mi­cro-M&A deal on Nas­daq?

Last week
Deals

FTC tar­gets in­sulin, threat­en­ing to go af­ter PBM-phar­ma deals that steer in­to 'com­mer­cial bribery'

Last week
Pharma
First page Previous page 12345 Next page Last page